Newsfile Corp
09 Nov 2026, 09:20 UTC · 5h ago
Kaplan Fox Announces a Securities Investigation into Madrigal Pharmaceuticals, Inc. (MDGL) - Investors Encouraged to Contact the Firm
Impact · against what's priced in
Madrigal Pharmaceuticals faces new potential legal liability following an investigation by Kaplan Fox & Kilsheimer LLP into securities violations. This introduces a legal overhang that may dampen institutional appeal and create downward pressure on the stock.
- MDGL−0.30
No priced-in read yet





